Baylor College of Medicine: Triggering Antiviral Immune Response in Certain Breast Cancers

HOUSTON, Texas, Jan. 16 (TNSRes) -- The Baylor College of Medicine issued the following news release:

Researchers at Baylor College of Medicine have discovered how therapeutics targeting RNA splicing can activate antiviral immune pathways in triple negative breast cancers (TNBC) to trigger tumor cell death and signal the body's immune response. A new study published in Cell shows that endogenous mis-spliced RNA in tumor cells mimics an RNA virus, leading tumor cells to self-destruct . . .

To gain access to full content fill out the form below.

Information Request Form

I'd like more information
Sign me up for a free trial

Name:
Newspaper/Company:
Email:
Phone:
State:
Keywords or Areas of Interest:

Select Product(s) you are interested in:
Daily Federal Tipoffs for your City/State
Congressional Vote Chart
Federal Contract Awards
Federal Patent Awards
News Releases from Federal Agencies
News Releases from States
News Releases from Counties
News Releases from Cities
Golf Handicap site (FairwayFiles.com)

Filling out this form will generate a contact, by phone or e-mail, from a TNS editor. No automated information is provided. How would you like to be contacted: Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Molly Chiu, 713-798-4710, molly.chiu2@bcm.edu